Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) per Heart Failure

D

Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Dheart\u002Dfailure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

In sintesi

Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

Key Statistics

0

Studi

--

Partecipanti

Positive

D

Grado

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
250-500 mg/day
antiagingprotocols:
500-1,000 mg/day

Limite massimo: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Momento migliore per l'assunzione: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated
  • Mild gastrointestinal discomfort
  • Flushing (rare)
  • Headache (rare)

Interazioni note

  • May interact with NAD+-dependent medications
  • Theoretical interaction with diabetes medications (may affect glucose metabolism)

Livello di assunzione massimo tollerabile: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does NMN (Nicotinamide Mononucleotide) help with Heart Failure?
Based on 0 studies with 0 participants, there is preliminary evidence that needs more research that NMN (Nicotinamide Mononucleotide) may support Heart Failure management. Our evidence grade is D (Very Early Research).
How much NMN (Nicotinamide Mononucleotide) should I take for Heart Failure?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of NMN (Nicotinamide Mononucleotide)?
Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Heart Failure?
We rate the evidence as Grade D (Very Early Research). This rating is based on 0 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.